Notice of Closed Meeting, 48469 [2023-15914]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 143 / Thursday, July 27, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Medicare & Medicaid
Services
Notice of Closed Meeting
[Document Identifier: CMS–10434]
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel;
(SEP)—PAR 18–812, NIOSH Member
Conflict Review.
Date: October 5, 2023.
Time: 1 p.m.–4 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1095 Willowdale Road, Morgantown,
West Virginia 26506. Telephone: (304)
285–5951; Email: MGoldcamp@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–15914 Filed 7–26–23; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:21 Jul 26, 2023
Jkt 259001
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
On May 28, 2010, the Office
of Management and Budget (OMB)
issued Paperwork Reduction Act (PRA)
guidance related to the ‘‘generic’’
clearance process. Generally, this is an
expedited clearance process by which
agencies may obtain OMB’s approval of
collection of information requests that
are ‘‘usually voluntary, low-burden, and
uncontroversial,’’ do not raise any
substantive or policy issues, and do not
require policy or methodological
review. The process requires the
submission of an overarching plan that
defines the scope of the individual
collections that may be submitted under
that umbrella. This notice is intended to
advise the public of our intent to extend
OMB’s approval of our MACPro
(Medicaid and CHIP Program) umbrella
and all of the individual generic
collection of information requests that
fall under that umbrella. This notice
also provides the public with general
instructions for obtaining documents
that are associated with such collections
and for submitting comments.
DATES: Comments must be received by
August 28, 2023.
ADDRESSES:
Submitting Comments When
commenting, please reference the
applicable collection’s CMS ID number
and/or the OMB control number (both
numbers are listed below under the
SUPPLEMENTARY INFORMATION caption).
To be assured consideration, comments
and recommendations must be
submitted in any one of the following
ways and by the applicable due date:
1. Electronically. We encourage you to
submit comments through the Federal
eRulemaking portal at the applicable
web address listed below under the
SUPPLEMENTARY INFORMATION caption
under ‘‘Docket Information.’’ If needed,
instructions for submitting such
comments can be found on that website.
2. By regular mail. Alternatively, you
can submit written comments to the
following address: CMS, Office of
Strategic Operations and Regulatory
Affairs (OSORA), Division of
SUMMARY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
48469
Regulations Development, Attention:
CMS–10434/OMB 0938–1188, Room
C4–26–05, 7500 Security Boulevard,
Baltimore, MD 21244–1850.
Obtaining Documents To obtain
copies of supporting statements and any
related forms and supporting documents
for the collections listed in this notice,
please refer to the following
instructions:
1. We encourage you to access the
Federal eRulemaking portal at the
applicable web address listed below
under the SUPPLEMENTARY INFORMATION
caption under ‘‘Docket Information.’’ If
needed, follow the online instructions
for accessing the applicable docket and
the documents contained therein.
FOR FURTHER INFORMATION CONTACT: For
general information contact William N.
Parham at 410–786–4669. For policy
related questions, contact the individual
listed below under the SUPPLEMENTARY
INFORMATION caption under ‘‘Docket
Information.’’
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), federal
agencies must obtain approval from
OMB for each collection of information
that they conduct or sponsor. The term
‘‘collection of information’’ is defined in
44 U.S.C. 3502(3) and 5 CFR 1320.3(c).
Generally, it applies to voluntary and
mandatory requirements that are related
to any one or more of the following
activities: the collection of information,
the reporting of information, the
disclose of information to a third-party,
and/or recordkeeping.
While there are some exceptions
(such as collections having nonsubstantive changes and collections
requesting emergency approval) section
3506(c)(2)(A) of the PRA requires
federal agencies to publish 60- and 30day notices in the Federal Register and
solicit comment on each of its proposed
collections of information, including:
new collections, extensions of existing
collections, revisions of existing
collections, and reinstatements of
previously approved collections before
submitting such collections to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Interested parties are invited to
submit comments regarding our burden
estimates or any other aspect of the
collection, including: the necessity and
utility of the proposed information
collection for the proper performance of
our agency’s functions; the accuracy of
burden estimates; ways to enhance the
quality, utility, and clarity of the
information to be collected; and the use
of automated collection techniques or
other forms of information technology to
E:\FR\FM\27JYN1.SGM
27JYN1
]]>Agencies
[Federal Register Volume 88, Number 143 (Thursday, July 27, 2023)]
[Notices]
[Page 48469]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15914]
[[Page 48469]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel; (SEP)--PAR 18-812, NIOSH Member
Conflict Review.
Date: October 5, 2023.
Time: 1 p.m.-4 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Michael Goldcamp, Ph.D.,
Scientific Review Officer, Office of Extramural Programs, National
Institute for Occupational Safety and Health, Centers for Disease
Control and Prevention, 1095 Willowdale Road, Morgantown, West Virginia
26506. Telephone: (304) 285-5951; Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-15914 Filed 7-26-23; 8:45 am]
BILLING CODE 4163-18-P
